Gravitas Collective Corp. to acquire Gravitas Life Sciences, LLC

Gravitas Collective Corp. has agreed to acquire Gravitas Life Sciences, LLC, a healthcare sector entity based in the United States. The strategic acquisition was announced on 23 July 2026, with a headline offer value of 3.5 million USD. The transaction consideration comprises a combination of loan notes and an earn-out mechanism, reflecting the structured nature of the financial arrangement agreed upon by the parties involved. This deal structure indicates a focus on future performance metrics alongside immediate financial commitment, which is common in private equity or strategic investments within the life sciences domain.

The deal was completed on 17 July 2026, preceding the public announcement date. This timeline suggests that regulatory or internal approvals were secured prior to the official disclosure to the market. The completion of the transaction marks the successful transfer of ownership and control from the previous stakeholders to Gravitas Collective Corp. The integration of Gravitas Life Sciences into the broader portfolio of the buyer is now underway, as the deal has moved past the closing phase. The transaction is subject to regulatory approval.